Klinische studies post-stamceltransplantatie

Mesenchymal stem cells

Infusion of mesenchymal stem cells as treatment for steroid resistant grade II to IV acute GVHD of poor graft function: a multicenter phase II study.

 

INCA 34176-254 

A Phase 2, Open-Label, Randomized, Multicenter Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease

Vragen en contact

Laatste aanpassing: 6 januari 2026